换一批
换一批The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
作者：
主题词
成年人(Adult);抗体, 单克隆(Antibodies, Monoclonal);抗体, 肿瘤(Antibodies, Neoplasm);抗肿瘤药(Antineoplastic Agents);队列研究(Cohort Studies);环孢菌素(Cyclosporine);巨细胞病毒(Cytomegalovirus);巨细胞病毒感染(Cytomegalovirus Infections);无病生存(Disease-Free Survival);供者选择(Donor Selection);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);免疫抑制剂(Immunosuppressive Agents);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);活体供者(Living Donors);淋巴细胞去除术(Lymphocyte Depletion);男(雄)性(Male);中年人(Middle Aged);骨髓摘除激动剂(Myeloablative Agonists);回顾性研究(Retrospective Studies);存活率(Survival Rate);T淋巴细胞(T-Lymphocytes);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);病毒激活(Virus Activation)
DOI
10.1016/j.bbmt.2008.09.001
PMID
18940684
发布时间
2017-11-16
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
